Gene · 1294
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neonatal Skin Blistering and Denudement Caused by Epidermolysis Bullosa. | Cureus | 2026 | 42699182 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa Classification and Current Approach to Diagnosis. | Pediatr Dermatol | 2026 | 42696398 | PubTator, text mining | PubMed |
| Targeting, Mutagenesis, and Functional Testing Strategies for Large Collagens. | Methods Mol Biol | 2026 | 42681148 | PubTator, text mining | PubMed |
| A PepFect14 analog improves non-viral CRISPR delivery in primary human cells to facilitate genome editing and repair. | Bioeng Transl Med | 2026 | 42666741 | PubTator, text mining | PubMed |
| Japanese intractable and rare dermatologic diseases: From the official skin-centered nanbyo core to an illustrative mechanism-based framework. | Intractable Rare Dis Res | 2026 | 42643679 | PubTator, text mining | PubMed |
| A variant of uncertain significance in COL7A1 in Bart syndrome: A case report. | JAAD Case Rep | 2026 | 42603996 | PubTator, text mining | PubMed |
| Molecular basis of collagen triple helix recognition by VWF A-like domain two of collagen VII: Implications for interlaced anchoring fibril formation. | J Biol Chem | 2026 | 42595117 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis identifies SMIM24 as a favorable prognostic biomarker in clear cell renal cell carcinoma. | Funct Integr Genomics | 2026 | 42587209 | PubTator, text mining | PubMed |
Topical gene therapy for severe recessive dystrophic epidermolysis bullosa: clinical outcomes and multidisciplinary management in three patients treated with beremagene geperpavec (B-VEC) in Italy - a case series. | Drugs Context | 2026 | 42578000 | PubTator, text mining | PubMed |
| Gene Therapy for Dystrophic Epidermolysis Bullosa. | Exp Dermatol | 2026 | 42568047 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies matrisomal gene associations in monogenic cerebral small vessel disease. | J Neurol | 2026 | 42481886 | PubTator, text mining | PubMed |
| A Case Report of Bart Syndrome with Brachydactyly of the Great Toe: A Rare Entity. | Clin Cosmet Investig Dermatol | 2026 | 42472082 | PubTator, text mining | PubMed |
| Revisiting Type VII Collagen Mislocalisation in Dystrophic Epidermolysis Bullosa Using High-Resolution Imaging. | Exp Dermatol | 2026 | 42469175 | PubTator, text mining | PubMed |
| Transcriptional-secretory uncoupling in RDEB skin creates a non-permissive microenvironment for sensory nerve regeneration. | Neurobiol Pain | 2026 | 42438698 | PubTator, text mining | PubMed |
| Esophageal Stricture in a 5-Year-Old Child with Epidermolysis Bullosa: Case Report of a Rare Complication at a Very Young Age. | Case Rep Gastroenterol | 2026 | 42416505 | PubTator, text mining | PubMed |
Development and Validation of a Six-Gene Signature of Myeloid Antigen Presentation Dysfunction Based on Single-Cell and Multi-Cohort Transcriptomics for Predicting Prognosis and Recurrence of Hepatocellular Carcinoma. | Cancer Inform | 2026 | 42404398 | PubTator, text mining | PubMed |
| Cutaneous embryology: Physiological basis and clinical implications. | J Eur Acad Dermatol Venereol | 2026 | 42403001 | PubTator, text mining | PubMed |
| Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatment. | Stem Cell Res Ther | 2026 | 42365332 | PubTator, text mining | PubMed |
| Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa. | Pediatr Dermatol | 2026 | 42349866 | PubTator, text mining | PubMed |
| Intravenous gentamicin therapy in children with severe recessive dystrophic epidermolysis bullosa with nonsense COL7A1 mutations. | Clin Exp Dermatol | 2026 | 42333467 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1294/papers